BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30159893)

  • 1. NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways.
    Ma H; Li T; Tao Z; Hai L; Tong L; Yi L; Abeysekera IR; Liu P; Xie Y; Li J; Yuan F; Zhang C; Yang Y; Ming H; Yu S; Yang X
    J Cell Physiol; 2019 Feb; 234(2):1630-1642. PubMed ID: 30159893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKCC1 Regulates Migration Ability of Glioblastoma Cells by Modulation of Actin Dynamics and Interacting with Cofilin.
    Schiapparelli P; Guerrero-Cazares H; Magaña-Maldonado R; Hamilla SM; Ganaha S; Goulin Lippi Fernandes E; Huang CH; Aranda-Espinoza H; Devreotes P; Quinones-Hinojosa A
    EBioMedicine; 2017 Jul; 21():94-103. PubMed ID: 28679472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR regulate EMT through RhoA and Rac1 pathway in prostate cancer.
    Chen X; Cheng H; Pan T; Liu Y; Su Y; Ren C; Huang D; Zha X; Liang C
    Mol Carcinog; 2015 Oct; 54(10):1086-95. PubMed ID: 25043657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways.
    Zhang Z; Yang M; Chen R; Su W; Li P; Chen S; Chen Z; Chen A; Li S; Hu C
    Oncogene; 2014 Jun; 33(26):3374-82. PubMed ID: 23975422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NKCC1 involvement in the epithelial-to-mesenchymal transition is a prognostic biomarker in gliomas.
    Sun H; Long S; Wu B; Liu J; Li G
    PeerJ; 2020; 8():e8787. PubMed ID: 32211242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCK promotes glioblastoma progression by TGFβ signaling.
    Wang Z; Ying C; Zhang A; Xu H; Jiang Y; Lou M
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32484210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
    Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB
    Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fbxw7 regulates tumor apoptosis, growth arrest and the epithelial-to-mesenchymal transition in part through the RhoA signaling pathway in gastric cancer.
    Li H; Wang Z; Zhang W; Qian K; Xu W; Zhang S
    Cancer Lett; 2016 Jan; 370(1):39-55. PubMed ID: 26458995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA.
    Kunigal S; Gondi CS; Gujrati M; Lakka SS; Dinh DH; Olivero WC; Rao JS
    Int J Oncol; 2006 Dec; 29(6):1349-57. PubMed ID: 17088972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways.
    Gulhati P; Bowen KA; Liu J; Stevens PD; Rychahou PG; Chen M; Lee EY; Weiss HL; O'Connor KL; Gao T; Evers BM
    Cancer Res; 2011 May; 71(9):3246-56. PubMed ID: 21430067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RND3 promotes Snail 1 protein degradation and inhibits glioblastoma cell migration and invasion.
    Liu B; Dong H; Lin X; Yang X; Yue X; Yang J; Li Y; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Mao S; Chen Q; Chang J
    Oncotarget; 2016 Dec; 7(50):82411-82423. PubMed ID: 27705942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Cichoric Acid on Colorectal Cancer: Impact on Migration, Epithelial-Mesenchymal Transition, and Proliferation
    Ma S; Huang Z; Chen Q; Yin X
    Discov Med; 2024 Jan; 36(180):190-198. PubMed ID: 38273759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. With-No-Lysine Kinase 3 (WNK3) stimulates glioma invasion by regulating cell volume.
    Haas BR; Cuddapah VA; Watkins S; Rohn KJ; Dy TE; Sontheimer H
    Am J Physiol Cell Physiol; 2011 Nov; 301(5):C1150-60. PubMed ID: 21813709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling.
    Zhang JG; Zhou HM; Zhang X; Mu W; Hu JN; Liu GL; Li Q
    BMC Cancer; 2020 Jan; 20(1):32. PubMed ID: 31931758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARL4C stabilized by AKT/mTOR pathway promotes the invasion of PTEN-deficient primary human glioblastoma.
    Chen Q; Weng HY; Tang XP; Lin Y; Yuan Y; Li Q; Tang Z; Wu HB; Yang S; Li Y; Zhao XL; Fu WJ; Niu Q; Feng H; Zhang X; Wang Y; Bian XW; Yao XH
    J Pathol; 2019 Feb; 247(2):266-278. PubMed ID: 30357833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
    Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K
    Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Significance of Combined Epithelial-Mesenchymal Transition Markers Expression and Role of Rac1 in Hepatocellular Carcinoma.
    Shin SK; Ryu S; Nam S; Ha SY; Kwon OS; Kim YS; Kim SH; Kim JH
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the Sodium-Potassium-Chloride Cotransporter Isoform-1 reduces glioma invasion.
    Haas BR; Sontheimer H
    Cancer Res; 2010 Jul; 70(13):5597-606. PubMed ID: 20570904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.
    Paradiso A; Cardone RA; Bellizzi A; Bagorda A; Guerra L; Tommasino M; Casavola V; Reshkin SJ
    Breast Cancer Res; 2004; 6(6):R616-28. PubMed ID: 15535843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans.
    Zhang L; Zhang W; Li Y; Alvarez A; Li Z; Wang Y; Song L; Lv D; Nakano I; Hu B; Cheng SY; Feng H
    Oncogene; 2016 Oct; 35(43):5641-5652. PubMed ID: 27041571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.